Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea

Completed · Phase 1 · Has a placebo group

Conditions studied: Rosacea, Erythema

In brief

This study will evaluate the safety and tolerability of AGN-199201 for the treatment of erythema associated with rosacea.

Key facts

Study ID

NCT01579084

Run by

Allergan

People needed

64

Starts

2012-04-01

Expected to finish

2012-06-01

Last updated by the study team

2019-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• facial erythema associated with rosacea on both sides of the face

You may not qualify if…

• Laser light-source or other energy based therapy in the last 6 months
• Excessive hair around the treatment area

Where it is running

• Study site — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.